Thematic Analysis
Semaglutide is a GLP-1 receptor agonist that is formulated for oral administration as Rybelsus®. Structurally, semaglutide is a lipid-modified alpha-helical peptide and its...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 2,309
- Institution
- Auckland University of Technology
External Links
Identifiers
- ORCID
- 0000-0002-6377-6194
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.